Checking catheter position beyond insertion
Neonav uses intravascular ECG to locate a catheter tip and provide ongoing migration surveillance. The approach is designed for neonatal and pediatric vascular access rather than only confirming placement once.
Bringing the device to US hospitals
The financing supports US commercialisation after FDA 510(k) clearance in 2025 and an expanded indication in 2026 that includes umbilical venous catheters. The company expects US sales to begin in 2026.
Where the funding goes
- Manufacturing expansion
- US commercial team
- US hospital launch